This study establishes PTILN as a distinct clinicopathological entity characterized by dominant tubulointerstitial damage with TBM immune deposits (IgG/C3/C1q), minimal glomerular involvement, demographic inversion (male predominance, elderly onset), and AKI-predominant presentation with subnephrotic proteinuria. This evidence concerns the gene C3 and acute kidney injury.